Sigma Metric Analysis
A recent study of the ADVIA 2120i hematology analyzer in Vietnam used the 2014 Ricos goals to assess quality. What if the CLIA 2025 goals were applied instead?
There's a new analyzer for hematology, the Atellica HEMA 580. A recent study looked at the its analytical performance in South Korea. Can the new analyzer meet the new CLIA 2025 goals?
A recent study looked at the analytical performance of a Roche cobas c301 in Dubai. Unfortunately, a few mistakes were made in the published version of the calculations. We correct them here.
A recent study looked at the analytical performance of a Erba XL 640 in Kolkata, India. A trend of poor performance is starting to emerge with the Erba analyzers. Is it the instrument? Or is it where the instruments are operated?
In 2025, An AIIMS study assessed the performance of an Abbott CELL-DYN Ruby hematology analyzer. This unique study not only assessed the instrument performance, it assessed the performance of the quality specifications themselves. Which goals are most appropriate for hematology analyzers today?